company background image
540686 logo

Smruthi Organics BSE:540686 Stock Report

Last Price


Market Cap







14 Jun, 2024


Company Financials

Smruthi Organics Limited

BSE:540686 Stock Report

Market Cap: ₹1.9b

540686 Stock Overview

Manufactures and markets active pharmaceutical ingredients (API) to pharmaceutical companies in India, Asia, Africa, the Americas, and internationally.

540686 fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance1/6
Financial Health6/6

Smruthi Organics Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Smruthi Organics
Historical stock prices
Current Share Price₹168.55
52 Week High₹218.80
52 Week Low₹118.90
1 Month Change0.96%
3 Month Change3.18%
1 Year Change25.41%
3 Year Change-42.86%
5 Year Change274.56%
Change since IPO190.44%

Recent News & Updates

Recent updates

Shareholder Returns

540686IN PharmaceuticalsIN Market

Return vs Industry: 540686 underperformed the Indian Pharmaceuticals industry which returned 54% over the past year.

Return vs Market: 540686 underperformed the Indian Market which returned 44.7% over the past year.

Price Volatility

Is 540686's price volatile compared to industry and market?
540686 volatility
540686 Average Weekly Movement6.0%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.6%
10% most volatile stocks in IN Market9.6%
10% least volatile stocks in IN Market4.3%

Stable Share Price: 540686 has not had significant price volatility in the past 3 months.

Volatility Over Time: 540686's weekly volatility (6%) has been stable over the past year.

About the Company


Smruthi Organics Limited manufactures and markets active pharmaceutical ingredients (API) to pharmaceutical companies in India, Asia, Africa, the Americas, and internationally. It API products include amlodipine besilate, losartan potassium, telmisartan, s - amlodipine besilate, s - amlodipine malelate, and valsartan for cardiovascular; metformin HCL, vildagliptin, teneligliptin, and dapagliflozin for anti-diabetic; ciprofloxacin HCL, diloxanide furoate, norfloxacin, and pefloxacin mesylate for anti-infective applications; and ticagrelor for anti-platelets. The company also offers drug intermediates, such as amlodipine base, s-amlodipine base, and phthaloyl amlodipine, as well as bulk drugs.

Smruthi Organics Limited Fundamentals Summary

How do Smruthi Organics's earnings and revenue compare to its market cap?
540686 fundamental statistics
Market cap₹1.93b
Earnings (TTM)₹35.90m
Revenue (TTM)₹1.28b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
540686 income statement (TTM)
Cost of Revenue₹723.54m
Gross Profit₹552.89m
Other Expenses₹516.99m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date


Earnings per share (EPS)3.14
Gross Margin43.32%
Net Profit Margin2.81%
Debt/Equity Ratio16.8%

How did 540686 perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.